HCV / HIV co-infection: a different perspective
Jmelnitzky, A.C.
Acta Gastroenterologica Latinoamericana 32(1): 7-10
2002
ISSN/ISBN: 0300-9033 PMID: 12136694 Document Number: 550504
The clinical significance of HCV-HIV co-infection has notoriously changed due to the introduction of new anti-retroviral therapeutic combinations against HIV infection. Their effectiveness in dramatically reducing AIDS mortality, and the corresponding increase in hospitalization and death related to liver disease. Considerations facing this new reality will have to include epidemiological aspects, pathogenetic interactions, the influence of highly active anti-retroviral therapies (HAART) on the natural history of HCV infection, including their HCV--enhanced liver toxicity, and current new strategies about therapeutic measures against HCV infection in the frame of the most recent advances in HIV therapy.